Schroeder, B.; Prasad, P.; Gbadegesin, O.; Gupta, S.; Frazer, R.; Heaney, S.; Franks, H.; Blair, C.; Stuttard, M.; Barlow, C.;
et al. Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare System. Cancers 2025, 17, 3935.
https://doi.org/10.3390/cancers17243935
AMA Style
Schroeder B, Prasad P, Gbadegesin O, Gupta S, Frazer R, Heaney S, Franks H, Blair C, Stuttard M, Barlow C,
et al. Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare System. Cancers. 2025; 17(24):3935.
https://doi.org/10.3390/cancers17243935
Chicago/Turabian Style
Schroeder, Benjamin, Prakrit Prasad, Ope Gbadegesin, Senjuti Gupta, Ricky Frazer, Smilla Heaney, Hester Franks, Cameron Blair, Matthew Stuttard, Clare Barlow,
and et al. 2025. "Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare System" Cancers 17, no. 24: 3935.
https://doi.org/10.3390/cancers17243935
APA Style
Schroeder, B., Prasad, P., Gbadegesin, O., Gupta, S., Frazer, R., Heaney, S., Franks, H., Blair, C., Stuttard, M., Barlow, C., Cook, H., Winter, H., d’Arienzo, P., Symington, J., Radif, Y., Rampes, S., Nathan, P., Young, K., Shaw, H.,
... Willis, M.
(2025). Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare System. Cancers, 17(24), 3935.
https://doi.org/10.3390/cancers17243935